MedPath

The efficacy and safety of neoadjuvant chemohormonal therapy followed by robot-assisted radical prostatectomy and/or radiation therapy for prostate cancer patients with oligometastasis: A prospective multicenter study

Not Applicable
Recruiting
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000046528
Lead Sponsor
Gifu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Bone metastasis with 4 part and greater The patients who have multiple lymph node metastases The patients cannot undergo robot-assisted radical prostatectomy due to comorbidities. The patients cannot undergo radiation therapy The patients who received chemotherapy The patients who have osteonecrosis of the jaw

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath